NCT02383134

Brief Summary

The achievement of peripheral nerve block requires several needle passes, with each of them being at risk of causing nerve injury either by direct trauma or intraneural injection even with the use of the ultrasound. The ultrasound guided supraclavicular brachial plexus block is known to be at risk of pneumothorax and / or nerve injury. This study is designed to determine the maximal effective distance away from the nerve for the injection to be effective.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2015

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 9, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
Last Updated

May 13, 2015

Status Verified

March 1, 2015

Enrollment Period

2 months

First QC Date

February 27, 2015

Last Update Submit

May 12, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Success of the ultrasound guided supraclavicular block at 30 minutes after injection at a specific distance of the needle tip from the outer sheeth of the nerve

    30 minutes

Secondary Outcomes (3)

  • •The onset time of sensory and motor block

    the block success will be assessed for each patient every 5 min for 30 mins in the operating room beginning when the needle exits the skin

  • The proportion of inadequate and failed blocks.

    the block success will be assessed for each patient every 5 min for 30 mins in the operating room beginning when the needle exits the skin

  • The presence of other complications such as hematoma, infection, pneumothorax.

    up to 48 hours post operative.

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing upper limb surgery surgery (hand, forearm, elbow)

You may qualify if:

  • ASA physical status I-III
  • years of age, inclusive
  • surgery less than 3 hours

You may not qualify if:

  • contraindications to brachial plexus block (e.g., allergy to local anesthetics, coagulopathy, malignancy or infection in the area)
  • existing neurological deficit in the area to be blocked
  • pregnancy
  • history of neck surgery or radiotherapy
  • inability to understand the informed consent and demands of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor, MD

Study Record Dates

First Submitted

February 27, 2015

First Posted

March 9, 2015

Study Start

May 1, 2015

Primary Completion

July 1, 2015

Study Completion

August 1, 2015

Last Updated

May 13, 2015

Record last verified: 2015-03